Catherine M. Szyman Edwards Lifesciences Corp (EW) insider trading activity

Catherine M. Szyman is CVP, Critical Care of Edwards Lifesciences Corp. Currently has a direct ownership of 81,287 shares of EW, which is worth approximately $6.13 Million. The most recent transaction as insider was on Mar 15, 2021, when has been sold 3,389 shares (Common Stock) at a price of $22.29 per share, resulting in proceeds of $75,541. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.3K

0% 3M change

133.5% 12M change

Total Value Held $6.13 Million

Catherine M. Szyman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2021	BUY Exercise of conversion of derivative security	$75,541 $22.29 p/Share	3,389 Added 10.11%	30,135 Common Stock
Feb 16 2021	SELL Open market or private sale	$298,910 $88.2 p/Share	3,389 Reduced 11.25%	26,746 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$75,541 $22.29 p/Share	3,389 Added 10.11%	30,135 Common Stock
Jan 15 2021	SELL Open market or private sale	$295,758 $87.27 p/Share	3,389 Reduced 11.25%	26,746 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$75,541 $22.29 p/Share	3,389 Added 10.11%	30,135 Common Stock
Oct 29 2020	SELL Open market or private sale	$1,490,800 $73.24 p/Share	20,355 Reduced 43.22%	26,746 Common Stock
Oct 29 2020	BUY Exercise of conversion of derivative security	$453,713 $22.29 p/Share	20,355 Added 30.18%	47,101 Common Stock

Also insider at

Outset Medical, Inc. Healthcare

Director

NARI

Inari Medical, Inc. Healthcare

Director

CMS